Home > PB Ratio > AUROBINDO PHARMA

AUROBINDO PHARMA
PB (Price/Book ) Ratio

The Current P/B Ratio of AUROBINDO PHARMA is 2.43.

Share Price ₹1,114.9Apr 18,2024
Market Cap ₹65,322.0 Cr
Book Value₹26,839.8 CrMar2023 - Consolidated Results
Price/Book 2.43xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of AUROBINDO PHARMA

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of AUROBINDO PHARMA is calculated as :

Current Market Cap [ ₹65,322.0 Cr] as on Apr 18,2024

(/) Book Value [ ₹26,839.8 Cr] based on Mar2023 - Consolidated Results

(=) P/B Ratio [ 2.43x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for AUROBINDO PHARMA , the investors are currently willing to pay '2.43 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of AUROBINDO PHARMA !

The chart below summarizes the trend in P/B Ratio of AUROBINDO PHARMA over the last five years.

Historical PB (Price/Book ) ratio chart of AUROBINDO PHARMA


PB Ratio Performance Analysis for AUROBINDO PHARMA

- AUROBINDO PHARMA 's latest p/b ratio is 2.43x.

- AUROBINDO PHARMA 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 1.97x.

- AUROBINDO PHARMA 's operated at median p/b ratio of 1.59x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, AUROBINDO PHARMA 's p/b ratio peaked in Mar2019 at 3.32x.

- AUROBINDO PHARMA 's p/b ratio hit its five-year low in Mar2023 of 1.13x.


How does AUROBINDO PHARMA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
AUROBINDO PHARMA 26,839.802.4365,322.0
SUN PHARMACEUTICAL INDUSTRIES LTD55,995.406.50364,015.0
CIPLA LTD23,346.004.66108,809.0
DR REDDYS LABORATORIES LTD23,140.404.3099,408.7
ZYDUS LIFESCIENCES LTD17,515.805.3894,213.7
DIVIS LABORATORIES LTD12,767.107.7398,684.0
MANKIND PHARMA LTD7,435.1612.9296,037.1
TORRENT PHARMACEUTICALS LTD6,198.0713.9186,219.0
LUPIN LTD12,315.605.9072,621.1
ABBOTT INDIA LTD3,146.0217.6055,366.4
ALKEM LABORATORIES LTD9,044.696.1555,582.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs AUROBINDO PHARMA 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.43x
Max industry PB 17.60x
Median industry PB 6.15x
Average industry PB 7.95x



You may also like the below Video Courses